Cancer BiologybioRxivPreprint
Targeting DNA Methylation Reactivates Type I Interferon Signalling in Bone-Metastatic Breast Cancer
Joan So, Thomas B Chadwick, Miriam Fuentes…·Belinda S. Parker
This study identifies Decitabine as a DNA hypomethylating agent that reactivates type I interferon signalling in bone-metastatic breast cancer, reducing metastatic potential.